Prognostic value of antibodies to Merkel cell polyomavirus T antigens and VP1 protein in patients with Merkel cell carcinoma

British Journal of Dermatology

Volumn 174, Issue 4, 2016, Pages 813-822

  Samimi, M ^a,b,c   Molet, L ^d,e   Fleury, M ^a,b,f   Laude, H ^d,e   Carlotti, A ^d   Gardair, C ^a,c   Baudin, M ^a,b   Gouguet, L ^a,b   Maubec, E ^g,h   Avenel Audran, M ⁱ   Esteve, E ^j   Wierzbicka Hainaut, E ^k   Beneton, N ^l   Aubin, F ^m   Rozenberg, F ^d,e   Dupin, N ^d,e   Avril, M F ^d,e   Lorette, G ^a,b,c   Guyetant, S ^a,c   Coursaget, P ^a,b   Touze A ^a,b   more..

^a UNIVERSITÉ DE TOURS   (France)

^b UR1282   (France)

^c UNIVERSITY HOSPITAL OF TOURS   (France)

^d Institut Cochin   (France)

^e INSTITUT COCHIN   (France)

^f UNIVERSITÉ D'ANGERS   (France)

^g BICHAT HOSPITAL   (France)

^h AVICENNE HOSPITAL   (France)

ⁱ ANGERS UNIVERSITY HOSPITAL   (France)

^j CENTRE HOSPITALIER RÉGIONAL D ORLÉANS   (France)

^k POITIERS UNIVERSITY HOSPITAL   (France)

^l CHR Le Mans   (France)

^m UNIVERSITÉ DE FRANCHE COMTÉ   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYTOKERATIN 20; MERKEL CELL POLYOMAVIRUS T ANTIGEN; PROTEIN VP1; UNCLASSIFIED DRUG; VIRUS ANTIGEN; CAPSID PROTEIN; TUMOR MARKER; VIRUS T ANTIGEN; VP1 PROTEIN, POLYOMAVIRUS;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURGERY; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MERKEL CELL POLYOMAVIRUS; MERKEL CELL TUMOR; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; RECURRENT DISEASE; REMISSION; VIRUS DETECTION; BLOOD; CLINICAL TRIAL; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOLOGY; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; POLYOMAVIRUS INFECTION; PROCEDURES; PROGNOSIS; RISK ASSESSMENT; SKIN TUMOR; TUMOR RECURRENCE; VERY ELDERLY; VIRUS INFECTION;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, VIRAL, TUMOR; BIOMARKERS, TUMOR; CAPSID PROTEINS; CARCINOMA, MERKEL CELL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MERKEL CELL POLYOMAVIRUS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POLYOMAVIRUS INFECTIONS; PROGNOSIS; RISK ASSESSMENT; SKIN NEOPLASMS; TUMOR VIRUS INFECTIONS;

EID: 84959047263     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.14313     Document Type: Article

References (37)

1. Agelli M, Clegg LX,. Epidemiology of primary Merkel cell carcinoma in the United States. J Am Acad Dermatol 2003; 49: 832-41.
2. Feng H, Shuda M, Chang Y, Moore PS,. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 2008; 319: 1096-100.
3. Bouvard V, Baan RA, Grosse Y, et al,. Carcinogenicity of malaria and of some polyomaviruses. Lancet Oncol 2012; 13: 339-40.
4. Shuda M, Arora R, Kwun HJ, et al,. Human Merkel cell polyomavirus infection I. MCV T antigen expression in Merkel cell carcinoma, lymphoid tissues and lymphoid tumors. Int J Cancer 2009; 125: 1243-9.
5. Shuda M, Kwun HJ, Feng H, et al,. Human Merkel cell polyomavirus small T antigen is an oncoprotein targeting the 4E-BP1 translation regulator. J Clin Invest 2011; 121: 3623-34.
6. Houben R, Shuda M, Weinkam R, et al,. Merkel cell polyomavirus-infected Merkel cell carcinoma cells require expression of viral T antigens. J Virol 2010; 84: 7064-72.
7. Angermeyer S, Hesbacher S, Becker JC, et al,. Merkel cell polyomavirus-positive Merkel cell carcinoma cells do not require expression of the viral small T antigen. J Invest Dermatol 2013; 133: 2059-64.
8. Kwun HJ, Shuda M, Feng H, et al,. Merkel cell polyomavirus small T antigen controls viral replication and oncoprotein expression by targeting the cellular ubiquitin ligase SCFFbw7. Cell Host Microbe 2013; 14: 125-35.
9. Borchert S, Czech-Sioli M, Neumann F, et al,. High-affinity Rb binding, p53 inhibition, subcellular localization, and transformation by wild-type or tumor-derived shortened Merkel cell polyomavirus large T antigens. J Virol 2014; 88: 3144-60.
10. Wendzicki JA, Moore PS, Chang Y,. Large T and small T antigens of Merkel cell polyomavirus. Curr Opin Virol 2015; 11C: 38-43.
11. Sihto H, Kukko H, Koljonen V, et al,. Clinical factors associated with Merkel cell polyomavirus infection in Merkel cell carcinoma. J Natl Cancer Inst 2009; 101: 938-45.
12. Laude HC, Jonchère B, Maubec E, et al,. Distinct Merkel cell polyomavirus molecular features in tumour and non tumour specimens from patients with Merkel cell carcinoma. PLoS Pathog 2010; 6: e1001076.
13. Touzé A, Gaitan J, Maruani A, et al,. Merkel cell polyomavirus strains in patients with Merkel cell carcinoma. Emerg Infect Dis 2009; 15: 960-2.
14. Touzé A, Le Bidre E, Laude H, et al,. High levels of antibodies against Merkel cell polyomavirus identify a subset of patients with Merkel cell carcinoma with better clinical outcome. J Clin Oncol 2011; 29: 1612-19.
15. Foulongne V, Dereure O, Kluger N, et al,. Merkel cell polyomavirus DNA detection in lesional and nonlesional skin from patients with Merkel cell carcinoma or other skin diseases. Br J Dermatol 2010; 162: 59-63.
16. Nakamura T, Sato Y, Watanabe D, et al,. Nuclear localization of Merkel cell polyomavirus large T antigen in Merkel cell carcinoma. Virology 2010; 398: 273-9.
17. Erovic BM, Al Habeeb A, Harris L, et al,. Significant overexpression of the Merkel cell polyomavirus (MCPyV) large T antigen in Merkel cell carcinoma. Head Neck 2013; 35: 184-9.
18. Rodig SJ, Cheng J, Wardzala J, et al,. Improved detection suggests all Merkel cell carcinomas harbor Merkel polyomavirus. J Clin Invest 2012; 122: 4645-53.
19. Kean JM, Rao S, Wang M, Garcea RL,. Seroepidemiology of human polyomaviruses. PLoS Pathog 2009; 5: e1000363.
20. Carter JJ, Paulson KG, Wipf GC, et al,. Association of Merkel cell polyomavirus-specific antibodies with Merkel cell carcinoma. J Natl Cancer Inst 2009; 101: 1510-22.
21. Pastrana DV, Tolstov YL, Becker JC, et al,. Quantitation of human seroresponsiveness to Merkel cell polyomavirus. PLoS Pathog 2009; 5: e1000578.
22. Tolstov YL, Pastrana DV, Feng H, et al,. Human Merkel cell polyomavirus infection II. MCV is a common human infection that can be detected by conformational capsid epitope immunoassays. Int J Cancer 2009; 125: 1250-6.
23. Chen T, Hedman L, Mattila PS, et al,. Serological evidence of Merkel cell polyomavirus primary infections in childhood. J Clin Virol 2011; 50: 125-9.
24. Nicol JTJ, Robinot R, Carpentier A, et al,. Age-specific seroprevalences of Merkel cell polyomavirus, human polyomaviruses 6, 7, and 9, and trichodysplasia spinulosa-associated polyomavirus. Clin Vaccine Immunol 2013; 20: 363-8.
25. Paulson KG, Carter JJ, Johnson LG, et al,. Antibodies to Merkel cell polyomavirus T antigen oncoproteins reflect tumor burden in Merkel cell carcinoma patients. Cancer Res 2010; 70: 8388-97.
26. Boccara O, Girard C, Mortier L, et al,. Guidelines for the diagnosis and treatment of Merkel cell carcinoma-Cutaneous Oncology Group of the French Society of Dermatology. Eur J Dermatol 2012; 22: 375-9.
27. Samimi M, Touzé A, Laude H, et al,. Vitamin D deficiency is associated with greater tumor size and poorer outcome in Merkel cell carcinoma patients. J Eur Acad Dermatol Venereol 2014; 28: 298-308.
28. Gardair C, Samimi M, Touzé A, et al,. Somatostatin receptors 2A and 5 are expressed in Merkel cell carcinoma with no association with disease severity. Neuroendocrinology 2015; 101: 223-35.
29. Warner CL, Cockerell CJ,. The new seventh edition American Joint Committee on Cancer staging of cutaneous non-melanoma skin cancer: a critical review. Am J Clin Dermatol 2011; 12: 147-54.
30. Paulson KG, Iyer JG, Blom A, et al,. Systemic immune suppression predicts diminished Merkel cell carcinoma-specific survival independent of stage. J Invest Dermatol 2013; 133: 642-6.
31. Touzé A, Gaitan J, Arnold F, et al,. Generation of Merkel cell polyomavirus (MCV)-like particles and their application to detection of MCV antibodies. J Clin Microbiol 2010; 48: 1767-70.
32. Fine JP, Gray RJ,. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999; 94: 496-509.
33. Benjamini Y, Hochberg Y,. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol 1995; 57: 289-300.
34. Bhatia K, Goedert JJ, Modali R, et al,. Merkel cell carcinoma subgroups by Merkel cell polyomavirus DNA: relative abundance and oncogene expression. Int J Cancer 2010; 126: 2240-6.
35. Schrama D, Peitsch WK, Zapatka M, et al,. Merkel cell polyomavirus status is not associated with clinical course of Merkel cell carcinoma. J Invest Dermatol 2011; 131: 1631-8.
36. Handschel J, Müller D, Depprich RA, et al,. The new polyomavirus (MCPyV) does not affect the clinical course in MCCs. Int J Oral Maxillofac Surg 2010; 39: 1086-90.
37. Vlahova L, Doerflinger Y, Houben R, et al,. P-cadherin expression in Merkel cell carcinomas is associated with prolonged recurrence-free survival. Br J Dermatol 2012; 166: 1043-52.